10.03.2011 • NewsEvonikRAG foundationKlaus Engel

Evonik Owners Expect IPO Decision in April

The owners of German chemical maker Evonik are mulling plans for an initial public offering (IPO) and expect to make a decision in April, a spokesman for majority owner RAG foundation said on Wednesday.

"The owners have started examining the details of an initial public offering," the spokesman for RAG said.

Evonik's chief executive, Klaus Engel, has reiterated repeatedly that the group has the potential to float and that preparations for a market debut were underway.

But in an interview with Germany's Handelsblatt daily published on Wednesday, he said that it may take up to around one year to conclude preparations for the IPO.

Private equity firm CVC Capital Partners bought a 25% stake in Evonik in 2008, which it still owns.

The European IPO market is picking up significantly and analysts and bankers are bracing for a flurry of listings over the next two months.

British racing team Williams Grand Prix Holdings floated on the Frankfurt stock exchange earlier this month. Container shipping company Hapag Lloyd and German property group GSW are tipped to float before Easter.

German bicycle maker Derby Cycle and software group RIB completed market debuts in February.

 

Company

Logo:

Evonik Industries AG

Rellinghauser Straße 1-11
45128 Essen
Germany

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.